GALECTIN THERAPEUTICS INC. Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31)
GALECTIN THERAPEUTICS INC. (GALT) reported Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) of 1.90% for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-28.
Discontinued › Notes › Fair Value Measures and Disclosures
us-gaap:FairValueAssumptionsRiskFreeInterestRate · last filed 2018-03-29
- GALECTIN THERAPEUTICS INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2016 was 1.90%.
- GALECTIN THERAPEUTICS INC. fair value assumptions, risk free interest rate (deprecated 2018-01-31) for fiscal 2015 was 1.84%.
| Period end | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 0 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 1 month | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2016-12-31 | 1.90% 10-K · filed 2017-03-28 | |||
| 2015-11-25 | 1.84% 10-K · filed 2017-03-28 | |||
| 2008-02-04 | 2.51% 10-K · filed 2014-03-21 | 2.51% 10-K · filed 2018-03-29 | 2.51% 10-K · filed 2013-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Arcturus Therapeutics Holdings Inc. (ARCT) | $0.402B | -2.05 | |
| Turn Therapeutics Inc. (TTRX) | United States | $0.397B | -25.68 |
| Opus Genetics, Inc. (IRD) | United States | $0.406B | -3.16 |
| RELMADA THERAPEUTICS, INC. (RLMD) | United States | $0.406B | -11.92 |
| ARS Pharmaceuticals, Inc. (SPRY) | United States | $0.414B | -3.70 |
| Atea Pharmaceuticals, Inc. (AVIR) | United States | $0.414B | -2.26 |
| Rezolute, Inc. (RZLT) | United States | $0.382B | -6.45 |
| DiaMedica Therapeutics Inc. (DMAC) | United States | $0.423B | -10.11 |
| PROTHENA CORP PUBLIC LTD CO (PRTA) | Ireland | $0.428B | -11.53 |
| CYPHERPUNK TECHNOLOGIES INC. (CYPH) | United States | $0.438B | -75.63 |